Results 91 to 100 of about 10,900 (261)

On the resuscitation of clinical freedom [PDF]

, 2010
Background: This paper is a response to the suggestion by Sacristán et al that clinicians can increase their clinical freedom by undertaking individualised economic analyses that demonstrate that interventions, which at a population level do not reach ...
Amanda Burls
core   +3 more sources

Palivizumab prophylaxis against respiratory syncytial virus infection in patients younger than 2 years of age with congenital heart disease

Annals of Saudi Medicine, 2021
BACKGROUND: Respiratory syncytial virus (RSV) is a viral pathogen that causes annual epidemics of lower respiratory tract infection with substantial morbidity and mortality in young children, especially those with congenital heart disease (CHD ...
Mohammed H. A. Mohammed, R. Agouba, Islam El Obaidy, F. Alhabshan, R. Abu-Sulaiman   +4 more
semanticscholar   +1 more source

Healthcare Utilization in Children Following Hospitalization for RSV‐ Versus Non‐RSV Related Lower Respiratory Tract Infections: A Nationwide Retrospective Study

Pediatric Pulmonology, Volume 61, Issue 1, January 2026.
ABSTRACT Introduction Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections (LRTIs) in young children. Additionally, RSV is associated with long‐term respiratory morbidities. This study evaluates acute and long‐term healthcare utilization (HCU) in infants hospitalized with RSV‐associated LRTI (RSV‐LRTI) compared to ...
Guy Hazan, Mai Ofri, Lital Hertz, Oliver Martyn, David Greenberg   +4 more
wiley   +1 more source

Palivizumab: Four Seasons in Russia

Annals of the Russian academy of medical sciences, 2014
In 2010, the Russian Federation (RF) registered palivizumab--innovative drug, based on monoclonal antibodies for passive immunization of seasonal respiratory syncytial virus (RSV) infection in children of disease severe progress risk group, which include primarily premature infants, children with bronchopulmonary dysplasia and hemodynamically ...
Baranov A.A., Ivanov D.O., Alyamovskaya G.A., Amirova V.R., Antonyuk I.V., Asmolova G.A., Belyaeva I.A., Bokeriya E.L., Bryukhanova O.A., Vinogradova I.V., Vlasova E.V., Galustyan A.N., Gafarova G.V., Gorev V.V., Davydova I.V., Degtyarev D.N., Degtyareva E.A., Dolgikh V.V., Donin I.M., Zakharova N.I., Zernova L.Yu., Zimina E.P., Zuev V.V., Keshishyan E.S., Kovalev I.A., Koltunov I.E., Korsunskii A.A., Krivoshchekov E.V., Krsheminskaya I.V., Kuznetsova S.N., Lyubimenko V.A., Namazova-Baranova L.S., Nesterenko E.V., Nikolaev S.V., Ovsyannikov D.Yu., Pavlova T.I., Potapova M.V., Rychkova L.V., Safarov A.A., Safina A.I., Skachkova M.A., Soldatova I.G., Turti T.V., Filatova N.A., Shakirova R.M., Yanulevich O.S.   +45 more
openaire   +5 more sources

Bridging Genomics and Clinical Medicine: RSVrecon Enhances RSV Surveillance With Automated Genotyping and Clinically Important Mutation Reporting

Influenza and Other Respiratory Viruses, Volume 20, Issue 1, January 2026.
ABSTRACT Background Respiratory Syncytial Virus (RSV) causes significant respiratory infections, particularly in young children and elderly adults. Genetic variations in the fusion (F) protein can reduce the efficacy of vaccination and monoclonal antibody treatments, emphasizing the need for genomic surveillance of this virus.
Lei Li, Haidong Yi, Jessica N. Brazelton, Richard J. Webby, Randall T. Hayden, Gang Wu, Diego R. Hijano   +6 more
wiley   +1 more source

Spatial and temporal variability of respiratory syncytial virus disease seasonality in Japan, 2012–2024

Pediatrics International, Volume 68, Issue 1, January/December 2026.
Abstract Background Understanding infectious disease seasonality is crucial to inform immunization timing and risk communications. This study aimed to describe trends in respiratory syncytial virus (RSV) seasonality in Japan by determining thresholds across 47 prefectures using public health surveillance data. Methods Weekly RSV cases per sentinel (CPS)
Takeshi Arashiro, Ichiro Morioka, Naruhiko Ishiwada, Oliver Martyn, Rolf Kramer, Jing Jin, Amanda Pinho, Ewen Corbelon, Satoshi Kusuda   +8 more
wiley   +1 more source

A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33–35 weeks of gestational age, based on data from the Spanish FLIP study [PDF]

, 2008
Background: The aim of this study, conducted in Europe, was to develop a validated risk factor based model to predict RSV-related hospitalisation in premature infants born 33-35 weeks' gestational age (GA).
Eric AF Simões, null null, Xavier Carbonell-Estrany, John R Fullarton, Johannes G Liese, Jose Figueras-Aloy, Gunther Doering, Juana Guzman   +7 more
core   +1 more source

Therapeutic Antibodies for Mosquito‐Borne Orthoflavivirus Infections: Discovery, Engineering Approaches, and Advances in mRNA‐Based Delivery Systems

Advanced Therapeutics, Volume 8, Issue 12, December 2025.
This review explores how antibody engineering and display technologies are driving therapeutic advances against mosquito‐borne orthoflaviviruses such as Zika, dengue, and yellow fever viruses. It highlights diverse neutralizing targets on the envelope protein, including the conserved fusion loop, and discusses how Fc engineering, rational antigen ...
Ana Clara Barbosa Antonelli, Lucas Silva Rodrigues, Maria Clara Moura Pinheiro, Sylvia Barbosa Pinhate, Marcelo de Macedo Brígido, Andréa Queiroz Maranhão   +5 more
wiley   +1 more source

Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus: A Systematic Review

Pediatrics, 2019
In this systematic review, we investigate the cost-effectiveness of palivizumab prophylaxis for RSV stratified by setting and infant population subgroups relevant to health-policy decision-making.
S. Mac, A. Sumner, Samuel Duchesne-Bélanger, R. Stirling, M. Tunis, B. Sander   +5 more
semanticscholar   +1 more source

Respiratory Syncytial Virus Epidemiology During and After Covid‐19 Pandemic in Africa: Systematic Review and Meta‐Analysis

Health Science Reports, Volume 8, Issue 12, December 2025.
ABSTRACT Background and Aims Respiratory syncytial virus (RSV) is a major agent of acute respiratory infections in children and the elderly. RSV epidemiology has been changed by the since Covid‐19 pandemic and this review aimed to assess the extent of this change in Africa.
Moussa Issa, Adamou Lagare, Goni A. M. Bachir, Arnol Bowo ‐Ngandji, Fatimata Hassane, Larwanou Harouna Magagi, Doutchi Mahamadou, Haoua Seini, Eric Adehossi, Alzouma Mayaki Zoubeirou   +9 more
wiley   +1 more source